Allomaron

Hyperuricemia of various origins, gout.

Inside, 1-3 tables. on the day after meals, with the obligatory use of at least 1.5-2 liters of liquid per day (under the control of diuresis). Treatment should begin with 1 table. daily with a gradual increase in the dose.

Hypersensitivity, hemochromatosis, severe renal impairment (with serum creatinine levels above 132.6 µmol / L (1.5 mg / 100 ml) or with glomerular filtration rate below 40 ml / min), pregnancy, breastfeeding, age (under 14 years).

Gastrointestinal disorders, diarrhea, vasculitis with skin manifestations and fever, liver and kidney damage, changes in the blood picture (leukopenia, thrombocytopenia), allergic reactions.

• Agents that affect the metabolism of uric acid

Increases the toxicity of azathioprine and mercaptopurine, the anticoagulant effect of coumarin derivatives, prolongs the effect of chlorpropamide, thiazide diuretics, etacrine and salicylic acid derivatives reduce the effect (increase the level of uric acid in the serum). When treated with iron preparations, it increases the accumulation of iron in the liver.

At room temperature.

Keep out of reach of children.

Do not use after the expiration date indicated on the package.

1 tablet, coated, contains allopurinol 100 mg and benzbromarone 20 mg, in a blister of 20 pcs.

M04AA51 Allopurinol in combination with other drugs

• E79. 0 Hyperuricemia without signs of inflammatory arthritis and gout nodes
• M10 Gout